Express Scripts says AbbVie drug could displace Sovaldi on formulary

By Ransdell Pierson (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said it may quickly change its preferred drug formulary to favor an expected new hepatitis C drug from AbbVie if it is clinically equivalent and less costly than Gilead Science Inc's $84,000 Sovaldi and $94,500 Harvoni treatments. Sovaldi, with its price tag of $1,000 a pill, has become a lightning rod in a debate over the high cost of specialty drugs, despite its cure rate of more than 90 percent and gentle side effect profile. ...



via Health News Headlines - Yahoo News http://news.yahoo.com/express-scripts-says-abbvie-drug-could-displace-sovaldi-180115886--finance.html